CHD4 mutations have previously been reported in AML and are particularly common in endometrial cancer.34,35 Inspection of crystal structures indicates variants are likely to interfere with DNA binding and ATPase function resulting in loss of function. The gene discussed is CHD4; the disease is endometrial cancer.